NCT01230008已完成不适用
Adjuvant Radiotherapy in Primary Mediastinal Lymphoma in Patients That Received R-CHOP
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 198
- 试验地点
- 1
- 主要终点
- measurement of progression free-survival and overall survival at > 5 years
研究概览
简要总结
The use of Rituximab has been proposed to be useful and avoid the use of radiotherapy in diffuse large B-cell lymphoma with bulky disease.We assess efficacy of adjuvant radiotherapy in patients treated with R-CHOP
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of primary mediastinal lymphoma No previous treatment performance status < 2 HIV, Hepatis B and C negative Normal :Renal, hepatic, pulmonary and cardiac function
排除标准
- 未提供
结局指标
主要结局
measurement of progression free-survival and overall survival at > 5 years
时间窗: 5 years
Assess if the use of adjuvant radiotherapy improve outcome in patients with primary mediastinal lymphoma treated initially with R-CHOP
次要结局
- assess toxicity secondary to mediastinal radiotherapy(> 5 years)
研究者
研究点 (1)
Loading locations...
相似试验
招募中
3 期
Early Stage Follicular LymphOma and RadioTherapy PLUS Anti-CD20 AntibodyEarly Stage Follicular Lymphoma WHO Grade 1/2 or 3aNCT05045664Heidelberg University100
终止
2 期
Predicting Cell Death by Radiation Therapy in Early Stage Non-small Cell Lung Cancer: a Prospective Translational TrialEarly Stage Non-small Cell Lung CancerNCT01138722University Hospital, Ghent1
已完成
2 期
Study to Evaluate the Efficacy of Rituximab in Combination With Low-dose Radiotherapy in Patients With Relapsed Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaNCT00147953University of Cologne30
已完成
2 期
Radiochemotherapy +/- Durvalumab for locally-advanced Anal Carcinoma. A multicenter, randomized, phase II trial of the German Anal Cancer Study GroupC21Malignant neoplasm of anus and anal canalDRKS00020739Goethe Universität; Universitätsklinikum Frankfurt Goethe-Universität180
招募中
1 期
Radiochemotherapy +/- Durvalumab for locally-advanced Anal CarcinomaA multicenter, randomized, phase II trial of the German Anal Cancer Study Groupanal cancer (UICC-Stage IIB-IIIC, incl. T2>4cm Nany )MedDRA version: 21.1Level: PTClassification code 10002136Term: Anal cancer stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: PTClassification code 10002137Term: Anal cancer stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-003005-25-ATniversity Hospital Frankfurt, Goethe University178